The Claim
In humans with obesity and type 2 diabetes, the antilipolytic effects of insulin and niacin are not independent because both are suppressed in parallel within individuals, challenging the notion that adipose tissue insulin resistance is a distinct, isolated defect.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with obesity and type 2 diabetes, insulin and niacin reduce fat breakdown together in the same individuals, indicating that insulin resistance in fat tissue is not a separate, isolated problem.
See the scientific wording
In humans with obesity and type 2 diabetes, the antilipolytic effects of insulin and niacin are not independent, as both are suppressed in parallel within individuals, challenging the notion that adipose tissue insulin resistance is a distinct, isolated defect.
In fat cells of people with obesity and type 2 diabetes, the proteins that control fat breakdown do not work properly, so neither insulin nor niacin can stop fat from being released, even though they start their signals in different ways.
What the research says
1 studyStudy: Adipose Tissue Resistance to the Antilipolytic Effect of Insulin and Niacin in Humans With Obesity.
In people with obesity or diabetes, when insulin can’t stop fat breakdown well, niacin also can’t stop it well — even though they work differently in the body. This means the problem isn’t just insulin failing alone, but something deeper in fat cells that breaks both systems at once.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.